DIAGNOSTIC VALUE OF P53 PROTEIN, EPIDERMAL GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN POLYPOID RHINOSINUSITIS
Abstract
Frequency of polyposis rhinosinusitis (PRS) has an accurate tendency of growth, speciʼnc gravity in the structure of a case rate of ENT organs makes 5-20%.Search of new approaches to early diagnosis and well-timed medicamental treatment of PRS is actual not only by his frequent relapsing, but also because a big prevalence of this disease.
References
1. Волков А.Г., Трофименко С.Л. К проблеме медикаментозного лечения хронического полипозного риносинусита // Вестник оториноларингологии, 2010. №4. с 41-44.
2. Лопатин А.С. Современные теории патогенеза полипозного риносинусита. // Пульмонология. – 2003. - №5.– С.110-116
3. EP3OS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rh-inosinusitis and Nasal Polyps 2012 – a summary. Prim Care Respir J 2012; 35: 3: 64–69.
4. Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumour angio-genesis and a potential target for diagnosis and therapy. J Clin Oncol 2004; 20:4368-80.
5. Ferrara N. The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS 2005; 2(94): 29-34.
6. Rotterud R., Nesland J.M., Berner A. Expression of the epidermal growth factor receptor family in normal and malignant urothelium// BJU Int., 2005, Jun;95(9):1344-50.
7. Skladzen J., Obtulowicz K., Miodonski A.et al. Allergic nasal polyps under scanning electron microscope // Med.Sci. Monit. 2001. Vol. 7(3). - P. 477-481.
